EdgarLookup

KORMAN HARRY

Insider transactions at 1 company

This page shows all SEC Form 4 filings attributed to KORMAN HARRY. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.

VTRS
Company Title Type Shares Price Value Date
VTRS Option Exercise 18,204 Mar 4, 2025
VTRS Option Exercise 885 Mar 3, 2024
VTRS Option Exercise 705 Mar 4, 2023
VTRS Option Exercise 166 Mar 21, 2022
VTRS Purchase 349 $13.94 $4,865 Mar 4, 2022
VTRS Option Exercise 335 Mar 2, 2022
VTRS Option Exercise 9,440 Mar 2, 2021
VTRS Award / Grant 26,515 Nov 16, 2020
0001623613 Disposition 26,515 Nov 16, 2020
0001623613 Tax Withholding 2,430 $17.48 $42,476 Mar 2, 2020
0001623613 Tax Withholding 1,882 $27.45 $51,661 Mar 2, 2019
0000069499 Chief Operating Officer Sale 31,970 $54.54 $1,743,644 Mar 6, 2014
0000069499 Chief Operating Officer Tax Withholding 5,613 $55.57 $311,914 Mar 2, 2014
0000069499 Chief Operating Officer Tax Withholding 1,937 $51.92 $100,569 Feb 22, 2014
0000069499 Chief Operating Officer Sale 9,814 $41.94 $411,599 Dec 11, 2013
0000069499 Chief Operating Officer Option Exercise 8,230 $12.15 $99,995 Mar 18, 2013
0000069499 Chief Operating Officer Tax Withholding 3,618 $30.10 $108,902 Mar 2, 2013
0000069499 Chief Operating Officer Tax Withholding 1,867 $28.98 $54,106 Feb 22, 2013
0000069499 Chief Operating Officer Option Exercise 28,188 $12.15 $342,484 Nov 6, 2012
0000069499 Chief Operating Officer Tax Withholding 584 $23.16 $13,525 Mar 2, 2012
0000069499 President, North America Option Exercise 5,300 $7.89 $41,817 Jan 22, 2008
0000069499 President, North America Option Exercise 6,000 $7.89 $47,340 Nov 13, 2007
0000069499 Pres., Mylan Pharmaceuticals Option Exercise 10,000 $7.89 $78,900 Jul 26, 2007
0000069499 Pres., Mylan Pharmaceuticals Tax Withholding 1,476 $21.91 $32,339 Feb 14, 2007
0000069499 Pres., Mylan Pharmaceuticals Option Exercise 120,000 $10.97 $1,316,400 Dec 14, 2006
0000069499 Pres., Mylan Pharmaceuticals Award / Grant 13,298 Feb 15, 2006